Emerald Therapeutics

Emerald Therapeutics

Emerald Therapeutics is a biotechnology company located in San Fransisco, California, founded by Brian Frezza and DJ Klienbaum in 2010. Emerald Therapeutics offers cloud a based software and hardware platform that allows researchers to remotely perform automated scientific laboratory experiments.

All edits

Edits on 1 May, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 1 May, 2020 3:08 am
Edits made to:
Article (+10/-10 characters)

Article

On December 27, 2010 Emerald Therapeutics announced their series A funding round and closed with $7,500,000 in funding from James HongJames Hong.

Edits on 30 April, 2020
Nico Faraguna
Nico Faraguna edited on 30 April, 2020 6:25 pm
Edits made to:
Infobox (--1 properties)

Infobox

B2X
Edits on 30 May, 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May, 2019 2:27 am
Edits made to:
Article (+11/-11 characters)

Article

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders Fund, and Max LevchinMax Levchin.

Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May, 2019 2:12 am
Edits made to:
Article (+29/-29 characters)

Article

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology InvestmentWestern Technology Investment, Sound Ventures, Schooner Capital, OS Fund, and Founders Fund.

Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May, 2019 2:11 am
Edits made to:
Article (+12/-12 characters)

Article

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay Area, California, and was founded in 2013 by Brian Frezza and DJ KleinbaumDJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab.

Edits on 29 May, 2019
Jed Christiansen
Jed Christiansen approved a suggestion from Golden's AI on 29 May, 2019 11:31 pm
Edits made to:
Article (+16/-16 characters)

Article

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner CapitalSchooner Capital, Founders Fund, and Max Levchin.

Golden AI
Golden AI edited on 29 May, 2019 2:58 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 28 March, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 28 March, 2019 10:31 pm
Edits made to:
Article (+14/-14 characters)

Article

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound VenturesSound Ventures, Schooner Capital, OS Fund, and Founders Fund.

Dawson Sewell
Dawson Sewell edited on 28 March, 2019 10:16 pm
Edits made to:
Infobox (+10/-1 properties)
Timeline (+4 events) (+703 characters)
Article (+583/-583 characters)
Categories (+1/-1 topics)
Related Topics (+2 topics)

Article

Emerald Therapeutics is a biotechnologybiotechnology company located in the San Francisco Bay Area, California, and was founded in 20102013 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab. The Emerald Cloud Lab provides researchers control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups.

The Emerald Cloud Lab provides researchers control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups.

Infobox

Categories

Related Topics

Timeline

June 19, 2015

Series C funding round

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound Ventures, Schooner Capital, OS Fund, and Founders Fund.

March 1, 2014

Series B funding round

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders Fund, and Max Levchin.

December 27, 2010

Series A funding round

On December 27, 2010 Emerald Therapeutics announced their series A funding round and closed with $7,500,000 in funding from James Hong.

2010

Founding of Emerald therapeutics

Emerald Therapeutics was founded in 2010 by Brian Frezza and DJ Kleinbaum

Edits on 4 February, 2019
Golden AI"Import data"
Golden AI edited on 4 February, 2019 11:07 pm
Edits made to:
Infobox (+1 properties)
People (+8 rows) (+16 cells) (+152 characters)

People

Name
Role
Related Golden topics

Ashby Monk

Investor

Eric Shyr

Employee

James Hong

Investor

James McKernan

Employee

John Tomcat Sanderson

Employee

Joi Ito

Investor

MJD MJD

Investor

Shan Sinha

Investor

Infobox

Edits on 16 January, 2019
Golden AI"Import data"
Golden AI edited on 16 January, 2019 7:56 pm
Edits on 9 January, 2019
Golden AI
Golden AI edited on 9 January, 2019 9:26 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 15 August, 2018
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 15 August, 2018 11:43 pm
Edits made to:
Article (+22/-22 characters)

Article

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay AreaSan Francisco Bay Area, California, and was founded in 2010 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab. The Emerald Cloud Lab provides researchers control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups.

Dawson Sewell
Dawson Sewell edited on 15 August, 2018 6:57 pm
Edits made to:
Description (+299/-209 characters)
Article (+2/-13 characters)
Topic thumbnail

Emerald Therapeutics

Emerald Therapeutics offers cloud a based software and hardware platform, called the Emerald Cloud Lab, that allows scientists to perform automated experiments in a centralized lab from anywhere in the world.

Emerald Therapeutics is a biotechnology company located in San Fransisco, California, founded by Brian Frezza and DJ Klienbaum in 2010. Emerald Therapeutics offers cloud a based software and hardware platform that allows researchers to remotely perform automated scientific laboratory experiments.

Article

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay Area, California , and was founded in 2010 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab. The Emerald Cloud Lab provides researchers with total control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups.

Thomas Shaddox
Thomas Shaddox approved a suggestion from Golden's AI on 15 August, 2018 6:44 pm
Edits made to:
Article (+10/-10 characters)

Article

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay Area, CaliforniaCalifornia and was founded in 2010 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab. The Emerald Cloud Lab provides researchers with total control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups.

Thomas Shaddox
Thomas Shaddox approved a suggestion from Golden's AI on 15 August, 2018 6:42 pm
Edits made to:
Article (+7/-7 characters)

Article

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound Ventures, Schooner Capital, OS FundOS Fund, and Founders Fund.

Thomas Shaddox
Thomas Shaddox approved a suggestion from Golden's AI on 15 August, 2018 6:42 pm
Edits made to:
Article (+13/-13 characters)

Article

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders FundFounders Fund, and Max Levchin.

Dawson Sewell
Dawson Sewell edited on 15 August, 2018 3:22 pm
Edits made to:
Description (+209 characters)
Article (+1486 characters)
People (+4 rows) (+8 cells) (+137/-7 characters)
Further reading (+1 rows) (+4 cells) (+195 characters)
Categories (+3 topics)
Topic thumbnail

Emerald Therapeutics

Emerald Therapeutics offers cloud a based software and hardware platform, called the Emerald Cloud Lab, that allows scientists to perform automated experiments in a centralized lab from anywhere in the world.

Article

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay Area, California and was founded in 2010 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab. The Emerald Cloud Lab provides researchers with total control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups.

Funding

Series A

On December 27, 2010 Emerald Therapeutics announced their series A funding round and closed with $7,500,000 in funding from James Hong.

Series B

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders Fund, and Max Levchin.

Series C

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound Ventures, Schooner Capital, OS Fund, and Founders Fund.

People

Name
Role
Related Golden topics

Brian Frezza

Co-Founder

Brian Singerman

Board Member

DJ Kleinbaum

FounderCo-Founder

Gaetano Moreloo

Chief Scientific Officer and Board Member

Jimmy Demesa

CEO

Further reading

Author
Title
Link
Type

James Temple

Founders Fund Backs a Robotic Lab that Puts Science in the Cloud

News Article

Infobox

Categories

Edits on 7 August, 2018
Jude Gomila
Jude Gomila edited on 7 August, 2018 2:01 am
Edits made to:
People (+1 rows) (+2 cells) (+19 characters)

People

Name
Role
Related Golden topics

DJ Kleinbaum

Founder

Edits on 1 May, 2018
Melanie Manipula
Melanie Manipula edited on 1 May, 2018 10:17 pm
Edits made to:
Topic thumbnail

Emerald Therapeutics

Emerald Therapeutics is a biotechnology company located in San Fransisco, California, founded by Brian Frezza and DJ Klienbaum in 2010. Emerald Therapeutics offers cloud a based software and hardware platform that allows researchers to remotely perform automated scientific laboratory experiments.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.